drug delivery

News

MSD says subcutaneous Keytruda matches IV form

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial.

News

Woman injecting herself while sat at a table

MIT team develops 'years-long' drug delivery tech

Researchers in the US have devised a new depot system that could provide months or even years of delivery from a single subcutaneous injection.

News

AstraZeneca buys cell therapy biotech for up to $1bn

AstraZeneca plans to acquire Belgian in vivo cell therapy biotech EsoBiotec and has signed a pair of licensing deals with drug delivery firm Alteogen.

News

Yellow water balloon and hand with needle

J&J files intravesical bladder cancer drug TAR-200 in US

Johnson & Johnson has started a marketing application in the US for TAR-200 as a treatment for non-muscle-invasive bladder cancer (NMIBC).

News

FDA sets August date for subcutaneous Leqembi decision

FDA has started its review of an autoinjector version of Eisai and Biogen's Alzheimer's drug Leqembi that could allow patients to be dosed at home.

News

NeOnc Technologies' founder, chief executive and chief scientific officer Thomas Chen

NeOnc Technologies has another go at a Nasdaq listing

US biotech NeOnc Technologies has applied to list on the Nasdaq as it advances a portfolio of drugs to treat diseases affecting the CNS.

MSD says subcutaneous Keytruda matches IV form

MIT team develops 'years-long' drug delivery tech

AstraZeneca buys cell therapy biotech for up to $1bn

J&J files intravesical bladder cancer drug TAR-200 in US

FDA sets August date for subcutaneous Leqembi decision

NeOnc Technologies has another go at a Nasdaq listing

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

drug delivery

Editor's Picks